Bristol-Myers Squibb Company (($BMY)) announced an update on their ongoing clinical study. Study Overview: Bristol-Myers ...

I reject the premise of the question,” MTA honcho Janno Lieber said when asked why a new subway tunnel would be built instead ...

Neumora Therapeutics Inc. (NASDAQ:NMRA) is one of the best IPO stocks to buy according to Wall Street analysts. Earlier on ...

Following FDA IND clearance for neuropathic pain, the Company is preparing to initiate its U.S. Phase 2a trial in Q4 2025 MIAMI, FL / ACCESS Newswire / August 19, 2025 / MIRA Pharmaceuticals, Inc.

Mabwell's 7MW4911 receives FDA IND clearance, paving the way for clinical trials targeting advanced GI cancers with promising ...

A major redevelopment project in East Greensboro is taking shape. The Nussbaum Center for Entrepreneurship’s Steelhouse is ...

MTA approves a $1.97-billion tunneling contract to extend the Second Avenue Subway into Harlem, adding three stations by 2032 ...

The 1.8-mile Lowline has been split into three design phases, and though there is an anticipated timeline for the first phase, there is currently no timeline for the remaining two.

SELLAS Life Sciences is developing GPS as a WT1 immunotherapy, which is in Phase 3 for AML. Click here to read why SLS stock ...

Texas Governor Abbott announces the opening of Timmerman Power Plant Phase One to bolster the state's energy infrastructure.